Weave Communications Inc (NYSE:WEAV), a provider of AI-powered patient engagement software for healthcare practices, reported financial results for the fourth quarter and full year 2025. The company delivered revenue growth in line with its consistent annual trend but presented a mixed picture relative to Wall Street's expectations, leading to a muted initial market reaction.
Earnings and Revenue Versus Estimates
For the critical fourth quarter, Weave's performance against analyst forecasts was nuanced. The company reported total revenue of $63.4 million, which represents a solid 17% year-over-year increase. However, this figure came in slightly below the consensus estimate of $64.45 million.
On the profitability front, the company's non-GAAP earnings per share (EPS) of $0.03 matched the analyst estimate of $0.0363 when rounded. This alignment on the bottom line, despite the slight revenue miss, suggests the company maintained control over its operational costs.
The key quarterly comparisons are as follows:
- Reported Q4 Revenue: $63.4 million
- Estimated Q4 Revenue: $64.45 million
- Reported Q4 Non-GAAP EPS: $0.03
- Estimated Q4 Non-GAAP EPS: $0.0363
Market Reaction and Outlook
The stock's performance in recent weeks reflects a period of consolidation and slight pressure, with shares down approximately 9.8% over the past two weeks and 14.5% over the past month. The immediate after-hours reaction to the earnings release was flat, indicating investors are digesting the results without a strong directional bias.
A significant point of focus is the company's provided outlook for 2026. Management's revenue guidance of $273.0 million to $276.0 million for the full year is notably higher than the current analyst consensus estimate of $280.36 million. For the first quarter of 2026, Weave expects revenue between $64.2 million and $64.8 million, which brackets the analyst estimate of $65.90 million.
The company also issued guidance for non-GAAP income from operations, projecting $8.0 to $12.0 million for the full year and $1.0 to $2.0 million for Q1.
Press Release Highlights
Beyond the headline numbers, Weave's earnings report emphasized strategic progress and operational improvements. CEO Brett White framed the company as evolving into an "always-on teammate" for healthcare practices through its expanding agentic workflows.
Key business and financial highlights from the report include:
- Full-Year 2025 Revenue: $239.0 million, a 17% increase from 2024.
- Customer Growth: Added 4,628 net new customer locations, ending the year with 39,625 total locations.
- Profitability Metrics: Non-GAAP income from operations turned positive for the full year, reaching $4.1 million compared to $0.8 million in 2024.
- Cash Flow: Generated $17.5 million in net cash from operating activities and $12.9 million in free cash flow for the year.
- Strategic Initiatives: Announced a partnership with patient financing provider CareCredit, launched an Insurance Eligibility product using robotic process automation, and was selected as the American Dental Association’s endorsed Patient Engagement solution.
Conclusion
Weave's fourth-quarter results depict a company maintaining steady growth and achieving a key milestone in non-GAAP operating profitability. The slight revenue miss was offset by an EPS meet and an ambitious full-year revenue forecast that outpaces current analyst expectations. The market's tempered reaction suggests investors are weighing the company's strong growth rate and improved profitability against the high bar set by its own guidance and the competitive SaaS landscape. The coming quarters will be crucial in demonstrating whether Weave can achieve its elevated 2026 targets and accelerate its path to sustained GAAP profitability.
For a detailed look at upcoming earnings dates and analyst estimate revisions, you can review the data here.
Disclaimer: This article is for informational purposes only and does not constitute investment advice, financial analysis, or a recommendation to buy or sell any security. The information presented is based on publicly available sources and should not be the sole basis for making investment decisions.